CyberKnife Market to Grow with a CAGR of 17.28% through 2029
Rising
increasing prevalence of cancer is expected to drive the Global CyberKnife
Market in the forecast period 2025-2029
According to
TechSci Research report, “CyberKnife Market – Global Industry Size, Share,
Trends, Competition Forecast & Opportunities, 2029”, the Global CyberKnife
Market stood at USD 448.24 million in 2023 and is anticipated to grow with a
CAGR of 17.28% through 2029. The increasing prevalence of
cancer, recent product launches, and growing preference for non-invasive or
minimally invasive procedures over surgery are the factors propelling the
growth of the global cyberKnife market.
The market experiences growth due to ongoing enhancements in CyberKnife technology. Innovations like real-time tumor tracking, advanced image guidance systems, and robotic precision have notably enhanced treatment outcomes. These advancements empower healthcare professionals to administer highly precise and targeted radiation therapy, minimizing harm to surrounding healthy tissues and mitigating side effects. Also, the rising global incidence of cancer serves as a significant driver for the CyberKnife market. Cancer stands as a primary cause of mortality and morbidity worldwide, amplifying the demand for effective treatment options. CyberKnife presents a non-invasive alternative to conventional surgery for cancer treatment, making it an appealing choice for patients ineligible for surgery or other standard treatments.
The CyberKnife system is a sophisticated blend of robotics, real-time imaging, and precise radiation delivery, engineered to target and eliminate abnormal tissue with unparalleled accuracy. Central to its operation is a remarkably agile robotic arm outfitted with a radiation delivery device. This arm boasts versatile movement capabilities, facilitating the delivery of radiation beams from multiple angles directly towards the tumor or lesion. To ensure precision, real-time imaging techniques like cone-beam computed tomography (CBCT) are employed, guaranteeing accurate radiation delivery to the intended target, even amidst patient movement during treatment.
A hallmark of CyberKnife technology is its adeptness in treating tumors located in intricate anatomical sites such as the brain, spine, and lungs. Its precision minimizes collateral damage to adjacent healthy tissues, resulting in fewer adverse effects and accelerated recovery periods compared to conventional surgery or alternative radiation therapies. By offering a non-invasive alternative that prioritizes patient comfort, quality of life, and treatment efficacy, CyberKnife epitomizes patient-centric care. With its adaptability, precision, and versatility, CyberKnife has revolutionized the landscape of medical technology, unlocking new horizons in oncology and beyond. As a pivotal player in modern healthcare, CyberKnife significantly contributes to improved patient outcomes and reshapes the paradigm of cancer treatment and beyond.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on "Global
CyberKnife Market”
The application scope of CyberKnife treatment is expanding beyond traditional oncology realms. There's a growing trend in utilizing CyberKnife for treating non-cancerous conditions like benign tumors, arteriovenous malformations (AVMs), and functional disorders such as trigeminal neuralgia. This shift highlights the versatility and potential of CyberKnife technology in addressing a wider range of diseases and conditions. In the CyberKnife market, collaborative partnerships among technology providers, healthcare institutions, and research organizations are becoming increasingly prevalent. These partnerships facilitate knowledge sharing, research collaborations, and the development of innovative treatment approaches. By leveraging the expertise of each partner, these collaborations aim to improve treatment outcomes, refine protocols, and propel technological advancements in CyberKnife systems.
Also,
support from regulatory bodies, research and development efforts, and a growing
global medical tourism trend further accelerate the expansion of the CyberKnife
market. According to the article, Cigarette smoking stands as the primary risk factor for lung cancer, accounting for approximately 80% to 90% of lung cancer-related fatalities in the United States. The utilization of alternative tobacco products, such as cigars or pipes, also elevates the likelihood of developing lung cancer. Tobacco smoke comprises over 7,000 chemicals, many of which are poisonous. Notably, at least 70 of these chemicals are identified as carcinogens, capable of causing cancer in humans or animals.
The Global CyberKnife
Market is segmented into application, end use, regional distribution, and
company
Based on end use,
the market is segmented into Hospitals, Outpatient facilities, Research and
Manufacturing. The hospital segment dominated the market in 2023. This is due
to the presence of highly skilled professionals and an increasing number of
patient visits in this facility are the major factors leading to the dominance
of the segment. Moreover, the rising number of hospitals in order to meet the
growing need of patients is also leading to segment growth. On the other hand, the outpatient facilities
segment is anticipated to register maximum growth during the forecast period.
Ambulatory surgical centers and specialty clinics are expected to experience
maximum growth during the forecast period. This is due to the advantages such
as a shorter waiting period and reduced overall cost and out-of-pocket expense
for the patients.
Major companies operating
in Global CyberKnife Market are:
- Accuray
Incorporated
- Varian
Medical Systems Inc.
- Koninklijke
Philips N.V.
- Hitachi,
Ltd.
- Mevion
Medical Systems
- Mitsubishi
Heavy Industries, Ltd.
- RaySearch
Laboratories
- Siemens
Healthineers AG
- ViewRay, Inc.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The increasing
prevalence of cancer, coupled with advancements in medical technology,
particularly the non-invasive nature of the CyberKnife system, is fueling the growth
of global cyberKnife market. Technological advancements like artificial
intelligence and expanding applications beyond cancer treatment also
contribute. Moreover, support from regulatory bodies, research and development
efforts, and a growing global medical tourism trend further accelerate the
expansion of the CyberKnife market in the forecast period” said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“CyberKnife Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Tumor, Cancer, Vascular malformation, Others), By End-use (Hospitals, Outpatient facilities, Research and Manufacturing), By Region and Competition, 2029F", has evaluated the future growth potential of Global CyberKnife
Market and provides statistics & information on market size, structure and
future market growth. The report intends to provide cutting-edge market
intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in Global CyberKnife Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com